NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

SBI Life Insurance Company Sees 13% YoY Growth in FY26

SBI Life Insurance Company has reported a 5% year-over-year (YoY) growth in Annual Premium Equivalent (APE) for the fourth quarter of FY26, driven by an increase in Premium Annuity and Retail Protection sales. On a full-year basis, the company registered a 13% YoY growth, with expectations of maintaining a similar growth trajectory over FY27-FY28E, in line with its guidance.

The company's Value of New Business (VNB) margin contracted to 28.4% in Q4FY26 and 27.5% for the full fiscal year, primarily due to the Goods and Services Tax (GST) exemption. However, we anticipate a gradual improvement in the VNB margin to 27.6% and 27.7% for FY27 and FY28E, respectively, as the negative impact of GST exemption diminishes and the company diversifies its product portfolio away from Unit Linked Insurance Plans (ULIP).

CompanyQ4FY26 APE Growth (YoY)FY26 APE Growth (YoY)
SBI Life Insurance Company5%13%

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

We have revised our estimate for SBI Life Insurance Company's multiple to 2.0x (vs. 2.5x earlier) and have valued the company using the Appraisal Value framework, with a target price of INR 2,200. Based on the company's healthy APE growth and margin outlook over FY26-28E, we have upgraded our recommendation to 'BUY'.

Investor Takeaway

Upgrade to 'BUY' on healthy APE growth and margin outlook over FY26-28E.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.